Clinical Trial
Antihypertensive efficacy of a new long acting hydralazine like vasodilator, ISF 2469 in combination with a betablocker and a diuretic
- PMID: 40887
Item in Clipboard
Clinical Trial
Antihypertensive efficacy of a new long acting hydralazine like vasodilator, ISF 2469 in combination with a betablocker and a diuretic
Int J Clin Pharmacol Biopharm.
1979 Oct.
No abstract available
Similar articles
-
[Treatment of severe arterial hypertension with propyldazine (ISF 2123) associated with a diuretic and a beta-blocking agent].Minerva Cardioangiol. 1979 Mar;27(3):113-8. Minerva Cardioangiol. 1979. PMID: 37462 Clinical Trial. Italian. No abstract available.
-
Cadralazine, a new vasodilator, in addition to a beta-blocker for long-term treatment of hypertension.Arzneimittelforschung. 1985;35(3):623-5. Arzneimittelforschung. 1985. PMID: 2859865
-
[Beta blockaders in the treatment of hypertension. Part 2. Antihypertensive effect: hypotheses on the mechanism of action and practical methods of treatment].Coeur Med Interne. 1978 Jul-Sep;17(3):381-400. Coeur Med Interne. 1978. PMID: 31260 Review. French. No abstract available.
-
Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances.Int J Clin Pharmacol Ther Toxicol. 1980;18(5):233-5. Int J Clin Pharmacol Ther Toxicol. 1980. PMID: 6104636 No abstract available.
-
Pharmacological basis for combination therapy of hypertension.Annu Rev Pharmacol Toxicol. 1977;17:311-23. doi: 10.1146/annurev.pa.17.040177.001523. Annu Rev Pharmacol Toxicol. 1977. PMID: 17355 Review. No abstract available.
Cited by
-
[14C]cadralazine: absorption, distribution and excretion in rat and dog.Eur J Drug Metab Pharmacokinet. 1983;8(1):25-33. doi: 10.1007/BF03189578. Eur J Drug Metab Pharmacokinet. 1983. PMID: 6861793
-
Studies on the metabolism of cadralazine in rat.Eur J Drug Metab Pharmacokinet. 1982 Jan-Mar;7(1):39-45. doi: 10.1007/BF03189541. Eur J Drug Metab Pharmacokinet. 1982. PMID: 7067722 No abstract available.
-
Acute systemic and renal haemodynamic effects and long-term antihypertensive action of cadralazine in patients pretreated with beta-blockers and diuretics.Eur J Clin Pharmacol. 1987;31(5):513-8. doi: 10.1007/BF00606622. Eur J Clin Pharmacol. 1987. PMID: 2881788 Clinical Trial.
-
Cadralazine versus prazosin as second-step treatment in hypertensive patients on beta-blockers: a randomized multicentre study. The Italian Multicentre Study Group.Eur J Clin Pharmacol. 1991;40(5):461-5. doi: 10.1007/BF00315223. Eur J Clin Pharmacol. 1991. PMID: 1679390 Clinical Trial.
-
Human pharmacokinetics of cadralazine: a new vasodilator.Eur J Drug Metab Pharmacokinet. 1985 Jul-Sep;10(3):217-23. doi: 10.1007/BF03189745. Eur J Drug Metab Pharmacokinet. 1985. PMID: 4085523 Clinical Trial.